1. 1970 - Schultes - The Botanical and Chemical Distribution of Hallucinogens.pdf
2. 1970 - Schultes - The Botanical and Chemical Distribution of Hallucinogens.pdf
3. 1970 - Schultes - The Botanical and Chemical Distribution of Hallucinogens.pdf
4. 1977 - Capps - Sceletium alkaloids Part 7 Structure and absolute stereochemistry of mesembrane.pdf
5. 1998 - al. - Depression in Parkinsons disease an EEG frequency analysis study.pdf
6. 1998 - al. - Depression in Parkinsons disease an EEG frequency analysis study.pdf
7. 2003 - Smet - Some ethnopharmacological notes on African hallucinogens.pdf
8. 2003 - Smet - Some ethnopharmacological notes on African hallucinogens.pdf
9. 2003 - Smet - Some ethnopharmacological notes on African hallucinogens.pdf
10. 2004 - O'Donnell - Antidepressant effects of inhibitors of cAMP phosphodiesterase PDE4.pdf
11. 2004 - O'Donnell - Antidepressant effects of inhibitors of cAMP phosphodiesterase PDE4.pdf
12. 2005 - Digby - Self-Medication and the Trade in Medicine within a Multi-Ethnic Context A Case Study of South Africa.pdf
13. 2005 - Digby - Self-Medication and the Trade in Medicine within a Multi-Ethnic Context A Case Study of South Africa.pdf
14. 2007 - Jin - Amaryllidaceae and Sceletium alkaloids.pdf
15. 2007 - Low - Different Histories of Buchu Euro-American Appropriation of San and Khoekhoe Knowledge of Buchu Plants.pdf
16. 2007 - Low - Different Histories of Buchu Euro-American Appropriation of San and Khoekhoe Knowledge of Buchu Plants.pdf
17. 2007 - Low - Khoisan Wind Hunting and Healing.pdf
18. 2007 - Low - Khoisan Wind Hunting and Healing.pdf
19. 2007 - Martorell - Ezcurra - The narrow-leaf syndrome a functional and evolutionary approach to the form of f.pdf
20. 2007 - Stafford - Monoamine oxidase inhibition by southern African traditional medicinal plants.pdf
21. 2007 - Stafford - Monoamine oxidase inhibition by southern African traditional medicinal plants.pdf
22. 2008 - Gericke - Sceletium a review update.pdf
23. 2008 - Gericke - Sceletium a review update.pdf
24. 2008 - Rothman - Dopamineserotonin releasers as medications for stimulant addictions.pdf
25. 2008 - Rothman - Dopamineserotonin releasers as medications for stimulant addictions.pdf
26. 2008 - Rothman - Dopamineserotonin releasers as medications for stimulant addictions.pdf
27. 2008 - Spina - PDE4 inhibitors current status.pdf
28. 2008 - Spina - PDE4 inhibitors current status.pdf
29. 2008 - Stafford - Review on plants with CNS-effects used in traditional South African medicine against mental diseases.pdf
30. 2008 - Wyk - A review of Khoi-San and Cape Dutch medical ethnobotany.pdf
31. 2008 - Wyk - A review of Khoi-San and Cape Dutch medical ethnobotany.pdf
32. 2008 - Wyk - A review of Khoi-San and Cape Dutch medical ethnobotany.pdf
33. 2008 - Wyk - A review of Khoi-San and Cape Dutch medical ethnobotany.pdf
34. 2009 - Morris - Morris Duretto 101 Aizoaceae version 20091 Flora of Tasmania Online.pdf
35. 2009 - Morris - Morris Duretto 101 Aizoaceae version 20091 Flora of Tasmania Online.pdf
36. 2010 - Patnala - HPLC Analysis of Mesembrine-Type Alkaloids in Sceletium Plant Material Used as An African Traditional Medicine.pdf
37. 2010 - Patnala - HPLC Analysis of Mesembrine-Type Alkaloids in Sceletium Plant Material Used as An African Traditional Medicine.pdf
38. 2011 - Harvey - Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum.pdf
39. 2011 - Harvey - Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum.pdf
40. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
41. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
42. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
43. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
44. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
45. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
46. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
47. 2011 - Leonti - The future is written Impact of scripts on the cognition selection knowledge and transmission of med.pdf
48. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
49. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
50. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
51. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
52. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
53. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
54. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
55. 2011 - Shikanga - In Vitro Permeation of Mesembrine Alkaloids from Sceletium tortuosum across Porcine Buccal Sublingua.pdf
56. 2011 - Smith - The effects of Sceletium tortuosum in an in vivo model of psychological stress.pdf
57. 2011 - Smith - The effects of Sceletium tortuosum in an in vivo model of psychological stress.pdf
58. 2011 - Wyk - The potential of South African plants in the development of new medicinal products.pdf
59. 2012 - Shikanga - The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations.pdf
60. 2012 - Shikanga - The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations.pdf
61. 2012 - Shikanga - The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations.pdf
62. 2012 - Shikanga - The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations.pdf
63. 2012 - Shikanga - The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations.pdf
64. 2012 - Shikanga - The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations.pdf
65. 2012 - Wen - The phosphodiesterase-4 PDE4 inhibitor rolipram decreases ethanol seeking and consumption in alcohol.pdf
66. 2012 - Wen - The phosphodiesterase-4 PDE4 inhibitor rolipram decreases ethanol seeking and consumption in alcohol.pdf
67. 2013 - Gericke - A Randomized Double-Blind Parallel-Group Placebo-Controlled Trial of Extract Sceletium tortuosum Zem.pdf
68. 2013 - Gericke - A Randomized Double-Blind Parallel-Group Placebo-Controlled Trial of Extract Sceletium tortuosum Zem.pdf
69. 2013 - Shyam - Role of Traditional and Alternative Medicine in Treatment of Ulcerative Colitis.pdf
70. 2013 - Street - Commercially Important Medicinal Plants of South Africa A Review.pdf
71. 2013 - Terburg - Acute Effects of Sceletium tortuosum Zembrin a Dual 5-HT Reuptake and PDE4 Inhibitor in the Human Am.pdf
72. 2013 - Terburg - Acute Effects of Sceletium tortuosum Zembrin a Dual 5-HT Reuptake and PDE4 Inhibitor in the Human Am.pdf
73. 2013 - Torregrossa - Learning to forget manipulating extinction and reconsolidation processes to treat addiction.pdf
74. 2013 - Torregrossa - Learning to forget manipulating extinction and reconsolidation processes to treat addiction.pdf
75. 2014 - Dimpfel - Electropharmacogram of Sceletium tortuosum extract based on spectral local field power in conscious.pdf
76. 2014 - Dimpfel - Electropharmacogram of Sceletium tortuosum extract based on spectral local field power in conscious.pdf
77. 2014 - Eiden - VMAT2 a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.pdf
78. 2014 - Eiden - VMAT2 a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.pdf
79. 2014 - Eiden - VMAT2 a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.pdf
80. 2014 - Loria - Effects of Sceletium tortuosum in rats.pdf
81. 2014 - Loria - Effects of Sceletium tortuosum in rats.pdf
82. 2014 - Medicine - Proof of Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium.pdf
83. 2014 - Medicine - Proof of Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium.pdf
84. 2014 - Medicine - Proof of Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium.pdf
85. 2014 - Naoi - Modulation of monoamine oxidase MAO expression in neuropsychiatric disorders genetic and environment.pdf
86. 2014 - Schell - Sceletium tortuosum and Mesembrine A Potential Alternative Treatment for Depression.pdf
87. 2015 - Pickard - Alternative models of addiction.pdf
88. 2015 - Schifano - Novel psychoactive substances of interest for psychiatry.pdf
89. 2015 - Schifano - Novel psychoactive substances of interest for psychiatry.pdf
90. 2015 - wemyss - Exploring Zembrin Extract Derived from South African Plant Sceletium tortuosum in Targeting cAMP-dri.pdf
91. 2015 - wemyss - Exploring Zembrin Extract Derived from South African Plant Sceletium tortuosum in Targeting cAMP-dri.pdf
92. 2016 - Coetzee - High-mesembrine Sceletium extract Trimesemine is a monoamine releasing agent rather than only a sele.pdf
93. 2016 - Fajemiroye - Treatment of anxiety and depression medicinal plants in retrospect.pdf
94. 2016 - Fajemiroye - Treatment of anxiety and depression medicinal plants in retrospect.pdf
95. 2016 - Kapewangolo - Sceletium tortuosum demonstrates in vitro anti-HIV and free radical scavenging activity.pdf
96. 2016 - Kapewangolo - Sceletium tortuosum demonstrates in vitro anti-HIV and free radical scavenging activity.pdf
97. 2016 - Morris - Royal pharmaceuticals Bioprospecting rights and traditional authority in South Africa.pdf
98. 2016 - Morris - Royal pharmaceuticals Bioprospecting rights and traditional authority in South Africa.pdf
99. 2017 - Khan - Quantification of mesembrine and mesembrenone in mouse plasma using UHPLCQToFMS Application to a pha.pdf
100. 2017 - Klak - Out of southern Africa Origin biogeography and age of the Aizooideae Aizoaceae.pdf
101. 2017 - Klak - Out of southern Africa Origin biogeography and age of the Aizooideae Aizoaceae.pdf
102. 2017 - Krstenansky - Mesembrine alkaloids - Review of their occurrence chemistry and pharmacology.pdf
103. 2017 - Krstenansky - Mesembrine alkaloids - Review of their occurrence chemistry and pharmacology.pdf
104. 2017 - Krstenansky - Mesembrine alkaloids - Review of their occurrence chemistry and pharmacology.pdf
105. 2017 - Lewis - Addiction and the Brain Development Not Disease.pdf
106. 2018 - Bennett - Immunomodulatory effects of Sceletium tortuosum TrimesemineTM elucidated in vitro_ Implications for.pdf
107. 2018 - Bennett - Immunomodulatory effects of Sceletium tortuosum TrimesemineTM elucidated in vitro_ Implications for.pdf
108. 2018 - Bennett - Immunomodulatory effects of Sceletium tortuosum TrimesemineTM elucidated in vitro_ Implications for.pdf
109. 2018 - Gericke - Kabbos Kwain The Past Present and Possible Future of Kanna.pdf
110. 2018 - Gericke - Kabbos Kwain The Past Present and Possible Future of Kanna.pdf
111. 2018 - Gericke - Kabbos Kwain The Past Present and Possible Future of Kanna.pdf
112. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
113. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
114. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
115. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
116. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
117. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
118. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
119. 2018 - Gericke - SCELETIUM EXTRACT AND USES THEREOF - EP 2408460 B1.pdf
120. 2018 - Nordling - How decolonization could reshape South African science.pdf
121. 2018 - Nordling - How decolonization could reshape South African science.pdf
122. 2018 - Nordling - How decolonization could reshape South African science.pdf
123. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
124. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
125. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
126. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
127. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
128. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
129. 2018 - Sandasi - Non-destructive quality assessment of herbal tea blends using hyperspectral imaging.pdf
130. 2018 - Veale - NMR structural elucidation of channaine an unusual alkaloid from Sceletium tortuosum.pdf
131. 2018 - Veale - NMR structural elucidation of channaine an unusual alkaloid from Sceletium tortuosum.pdf
132. 2018 - Veale - NMR structural elucidation of channaine an unusual alkaloid from Sceletium tortuosum.pdf
133. 2018 - Volkow - Neurobiology of addiction a neurocircuitry analysis.pdf
134. 2018 - Volkow - Neurobiology of addiction a neurocircuitry analysis.pdf
135. 2018 - Zhao - 1H-NMR and UPLC-MS metabolomics Functional tools for exploring chemotypic variation in Sceletium tor.pdf
136. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
137. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
138. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
139. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
140. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
141. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
142. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
143. 2019 - Druart - Emerging Roles of Complement in Psychiatric Disorders.pdf
144. 2019 - Manganyi - Antibacterial activity of endophytic fungi isolated from Sceletium tortuosum L. Kougoed.pdf
145. 2019 - Manganyi - Antibacterial activity of endophytic fungi isolated from Sceletium tortuosum L. Kougoed.pdf
146. 2019 - Manganyi - Antibacterial activity of endophytic fungi isolated from Sceletium tortuosum L. Kougoed.pdf
147. 2019 - Manganyi - Antibacterial activity of endophytic fungi isolated from Sceletium tortuosum L. Kougoed.pdf
148. 2019 - Manganyi - Antibacterial activity of endophytic fungi isolated from Sceletium tortuosum L. Kougoed.pdf
149. 2019 - Manganyi - Antibacterial activity of endophytic fungi isolated from Sceletium tortuosum L. Kougoed.pdf
150. 2019 - Mintah - Medicinal Plants for Treatment of Prevalent Diseases.pdf
151. 2019 - Mintah - Medicinal Plants for Treatment of Prevalent Diseases.pdf
152. 2019 - Yin - Sceletorines A and B two minor novel dimeric alkaloids of Mesembryanthemum tortuosum synonym Sceleti.pdf
153. 2019 - Yin - Sceletorines A and B two minor novel dimeric alkaloids of Mesembryanthemum tortuosum synonym Sceleti.pdf
154. 2019 - Yin - Sceletorines A and B two minor novel dimeric alkaloids of Mesembryanthemum tortuosum synonym Sceleti.pdf
155. 2020 - Akinyede - Review Ethnopharmacology Therapeutic Properties and Nutritional Potentials of Carpobrotus edulis.pdf
156. 2020 - Akinyede - Review Ethnopharmacology Therapeutic Properties and Nutritional Potentials of Carpobrotus edulis.pdf
157. 2020 - Badmaev3 - Sceletium tortuosum Zembrin ameliorates experimentally induced anxiety in healthy volunteers.pdf
158. 2020 - Badmaev3 - Sceletium tortuosum Zembrin ameliorates experimentally induced anxiety in healthy volunteers.pdf
159. 2020 - Badmaev3 - Sceletium tortuosum Zembrin ameliorates experimentally induced anxiety in healthy volunteers.pdf
160. 2020 - Carlier - Pharmacology of Herbal Sexual Enhancers A Review of Psychiatric and Neurological Adverse Effects.pdf
161. 2020 - Carlier - Pharmacology of Herbal Sexual Enhancers A Review of Psychiatric and Neurological Adverse Effects.pdf
162. 2020 - Carlier - Pharmacology of Herbal Sexual Enhancers A Review of Psychiatric and Neurological Adverse Effects.pdf
163. 2020 - Carlier - Pharmacology of Herbal Sexual Enhancers A Review of Psychiatric and Neurological Adverse Effects.pdf
164. 2020 - Carlier - Pharmacology of Herbal Sexual Enhancers A Review of Psychiatric and Neurological Adverse Effects.pdf
165. 2020 - Said - Antidepressant potential of Mesembryanthemum cordifolium roots assisted by metabolomic analysis.pdf
166. 2020 - Said - Antidepressant potential of Mesembryanthemum cordifolium roots assisted by metabolomic analysis.pdf
167. 2020 - Said - Antidepressant potential of Mesembryanthemum cordifolium roots assisted by metabolomic analysis.pdf
168. 2020 - Said - Antidepressant potential of Mesembryanthemum cordifolium roots assisted by metabolomic analysis.pdf
169. 2020 - Said - Antidepressant potential of Mesembryanthemum cordifolium roots assisted by metabolomic analysis.pdf
170. 2020 - Said - Antidepressant potential of Mesembryanthemum cordifolium roots assisted by metabolomic analysis.pdf
171. 2021 - Ateba - A Chewable Cure Kanna Biological and Pharmaceutical Properties of Sceletium tortuosum.pdf
172. 2021 - Ateba - A Chewable Cure Kanna Biological and Pharmaceutical Properties of Sceletium tortuosum.pdf
173. 2021 - Berk - Plant-based Medicines Phytoceuticals in the Treatment of Psychiatric Disorders A Meta-review of Meta.pdf
174. 2021 - Berk - Plant-based Medicines Phytoceuticals in the Treatment of Psychiatric Disorders A Meta-review of Meta.pdf
175. 2021 - Berk - Plant-based Medicines Phytoceuticals in the Treatment of Psychiatric Disorders A Meta-review of Meta.pdf
176. 2022 - Jun - A network pharmacology-based approach to explore the therapeutic potential of Sceletium tortuosum in.pdf
177. 2022 - Jun - A network pharmacology-based approach to explore the therapeutic potential of Sceletium tortuosum in.pdf
178. 2022 - PI - Psychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract Zembrin.pdf
179. 2022 - PI - Psychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract Zembrin.pdf
180. 2022 - PI - Psychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract Zembrin.pdf
181. 2025 - Lepule - Neuroprotective and neurorestorative properties of Mesembryanthemum tortuosum in a Parkinsons diseas.pdf
182. 2025 - Lepule - Neuroprotective and neurorestorative properties of Mesembryanthemum tortuosum in a Parkinsons diseas.pdf
